Catherine Moukheibir sold $518k of IRWD
director at IRONWOOD PHARMACEUTICALS INC. 80,000 shares at an average of $6.47, traded Jun 6, 2024, filed Jun 10, 2024.
Score components
- +15RoleDirector
- +18Trade size$518k at market
- +20Share of holdings soldSold 62% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -1.2%, 3m -39.1%, 6m -39.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-071393, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 6, 2024 | SOpen-market sale Class A Common Stock | -44,426 | $6.36 | $283k | 84,207 | Jun 10, 2024 |
| Jun 7, 2024 | SOpen-market sale Class A Common Stock | -35,574 | $6.61 | $235k | 48,633 | Jun 10, 2024 |
Related signals
Other insiders at IRONWOOD PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 24Weak | IRONWOOD PHARMACEUTICALS INC | Ronald Silver PFO & PAO | $578k 127,890 shares | -29% | |
| 4Weak | IRONWOOD PHARMACEUTICALS INC | Julie McHugh director | $80k 21,571 shares | -8% | |
| 50Moderate | IRWDsell IRONWOOD PHARMACEUTICALS INC | Alexander J Denner director | $21M 6,730,800 shares | -42% | |
| 39Weak | IRONWOOD PHARMACEUTICALS INC | Tammi L Gaskins Chief Commercial Officer | $80k 21,526 shares | -9% | |
| 39Weak | IRONWOOD PHARMACEUTICALS INC | Ronald Silver Principal Accounting Officer | $90k 24,173 shares | -9% | |
| 66Notable | IRONWOOD PHARMACEUTICALS INC | Thomas A MCCOURT Chief Executive Officer | $740k 198,283 shares | -12% | |
| 40Moderate | IRONWOOD PHARMACEUTICALS INC | Michael Shetzline SVP, CMO, Head-Res&Drug | $122k 32,582 shares | -6% | |
| 41Moderate | IRONWOOD PHARMACEUTICALS INC | Minardo John Chief Legal Officer | $136k 36,492 shares | -9% | |
| 51Moderate | IRONWOOD PHARMACEUTICALS INC | Gregory S. Martini Chief Financial Officer | $82k 21,944 shares | -12% | |
| 11Weak | IRONWOOD PHARMACEUTICALS INC | Ronald Silver Principal Accounting Officer | $163k 35,416 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.